Breaking News Instant updates and real-time market news.

JAKK

JAKKS Pacific

$8.35

0.25 (3.09%)

06:01
10/17/16
10/17
06:01
10/17/16
06:01

JAKKS Pacific acquires C'est Moi brand

JAKKS Pacific announced the acquisition of C'est Moi, an innovative skincare and performance makeup brand specially formulated for kids 4 to 12 years old.

  • 20

    Oct

JAKK JAKKS Pacific
$8.35

0.25 (3.09%)

10/27/15
BMOC
10/27/15
UPGRADE
BMOC
Outperform
JAKKS Pacific upgraded on valuation at BMO Capital
As noted earlier, BMO Capital upgraded JAKKS to Outperform from Market Perform. The firm upgraded the stock on valuation. Target to $11 from $10.50.
10/27/15
10/27/15
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: APR Energy (APRYY) upgraded to Hold from Underperform at Jefferies... Capital Product (CPLP) upgraded to Outperform from Market Perform at Wells Fargo... Cheesecake Factory (CAKE) upgraded to Buy from Neutral at BTIG... Columbia Sportswear (COLM) upgraded to Neutral from Underperform at Macquarie... Dr Pepper Snapple (DPS) upgraded on positive catalysts at RBC Capital... JAKKS Pacific (JAKK) upgraded to Outperform from Market Perform at BMO Capital... Phillips 66 Partners (PSXP) upgraded to Outperform from Neutral at Credit Suisse... UDR, Inc. (UDR) upgraded to Neutral from Underperform at Credit SuissevVMware (VMW) upgraded to Buy from Hold at Drexel Hamilton... Valeant (VRX) upgraded to Buy from Neutral at Mizuho... Weatherford (WFT) upgraded to Positive at Susquehanna.
12/02/15
PIPR
12/02/15
NO CHANGE
Target $11
PIPR
Overweight
JAKKS Pacific positioned for 2015 upside, says Piper Jaffray
After meeting with management, Piper Jaffray analyst Stephanie Wissink continues to believe JAKKS Pacific is well positioned for upside to its 2015 guidance. Management comments around holiday sales for the toy category imply strong sales trends, Wissink tells investors in a research note. She keeps an Overweight rating on the name with an $11 price target.
02/23/16
PIPR
02/23/16
NO CHANGE
Target $11
PIPR
Overweight
Piper a buyer of JAKKS Pacific at current levels
Piper Jaffray analyst Stephanie Wissink says her firm is a buyer of JAKKS Pacific following the company's Q4 results. The quarter was in-line and the 2016 outlook was better than expected, Wissink tells investors in a post-earnings research note. The stock is trading at a "steeply discounted level" relative to peers, the analyst contends. Wissink keeps an Overweight rating on JAKKS with an $11 price target.

TODAY'S FREE FLY STORIES

CEQP

Crestwood Equity

$26.40

-0.6 (-2.22%)

07:05
02/21/17
02/21
07:05
02/21/17
07:05
Earnings
Crestwood Equity reports Q4 EPS ($1.20), may not compare to consensus 16c »

Reports Q4 revenue $795M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 02

    Mar

MDT

Medtronic

$78.88

0.89 (1.14%)

07:05
02/21/17
02/21
07:05
02/21/17
07:05
Earnings
Medtronic backs FY17 EPS $4.55-$460, consensus $4.56 »

The company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

WMT

Wal-Mart

$69.37

0.5 (0.73%)

07:05
02/21/17
02/21
07:05
02/21/17
07:05
Earnings
Wal-Mart sees Q1 EPS of 90c-$1.00, consensus 96c »

For the 13-week period…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

  • 14

    Mar

  • 19

    Mar

XCRA

Xcerra

$8.30

0.13 (1.59%)

07:04
02/21/17
02/21
07:04
02/21/17
07:04
Earnings
Xcerra sees Q3 non-GAAP EPS 10c-14c, consensus 8c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREX

Trex Company

$69.81

-0.76 (-1.08%)

07:04
02/21/17
02/21
07:04
02/21/17
07:04
Earnings
Trex Company sees Q1 net sales approx. $144M, consensus $143.28M »

Incremental gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

WMT

Wal-Mart

$69.37

0.5 (0.73%)

07:04
02/21/17
02/21
07:04
02/21/17
07:04
Earnings
Wal-Mart reports Q4 adjusted EPS $1.30, consensus $1.29 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

  • 14

    Mar

  • 19

    Mar

TREX

Trex Company

$69.81

-0.76 (-1.08%)

07:03
02/21/17
02/21
07:03
02/21/17
07:03
Hot Stocks
Trex Company board approves new 2.96M share repurchase program »

The Company's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

TREX

Trex Company

$69.81

-0.76 (-1.08%)

07:03
02/21/17
02/21
07:03
02/21/17
07:03
Earnings
Trex Company reports Q4 EPS 43c, consensus 41c »

Reports Q4 revenue $95M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

XCRA

Xcerra

$8.30

0.13 (1.59%)

07:02
02/21/17
02/21
07:02
02/21/17
07:02
Earnings
Xcerra reports Q2 non-GAAP EPS 6c, consensus (2c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$61.65

-0.14 (-0.23%)

07:01
02/21/17
02/21
07:01
02/21/17
07:01
Hot Stocks
Six Flags signs agreement to build Six Flags-branded parks at second China site »

Six Flags Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

INOV

Inovalon

$11.30

-0.45 (-3.83%)

07:01
02/21/17
02/21
07:01
02/21/17
07:01
Recommendations
Inovalon analyst commentary  »

Piper sees lawsuit as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SRPT

Sarepta

$28.28

0.31 (1.11%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Hot Stocks
Sarepta agrees to sale of priority review voucher for $125M »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

SEAS

SeaWorld

$19.21

-0.03 (-0.16%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Earnings
Breaking Earnings news story on SeaWorld »

SeaWorld reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TVPT

Travelport

$14.14

-0.06 (-0.42%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Travelport reports Q4 adjusted EPS 23c, consensus 20c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

MDT

Medtronic

$78.88

0.89 (1.14%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Medtronic reports Q3 EPS $1.12, consensus $1.11 »

Reports Q3 revenue $7.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

REXR

Rexford Industrial

$22.92

0.24 (1.06%)

06:57
02/21/17
02/21
06:57
02/21/17
06:57
Hot Stocks
Rexford Industrial acquires industrial property in Los Angeles for $17.1M »

Rexford Industrial Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$41.74

0.36 (0.87%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Hot Stocks
Loxo Oncology completes enrollment for larotrectinib NDA »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$30.37

-0.08 (-0.26%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Periodicals
GE succession plan near top of investors' minds, WSJ says »

General Electric CEO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVN

Trevena

$7.13

0.1 (1.42%)

06:55
02/21/17
02/21
06:55
02/21/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Trevena »

Trevena trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 21

    Mar

TIF

Tiffany

$86.18

3.17 (3.82%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Tiffany, JANA Partners announce agreement to appoint 3 new independent directors »

Tiffany and JANA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Breaking Hot Stocks news story on Enable Midstream »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:53
02/21/17
02/21
06:53
02/21/17
06:53
Earnings
Enable Midstream reports Q4 EPS 14c, consensus 18c »

Reports Q4 revenue $614M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WLK

Westlake Chemical

$61.66

-0.99 (-1.58%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Earnings
Westlake Chemical reports Q4 EPS 76c with items, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JNCE

Jounce Therapeutics

$19.90

0.24 (1.22%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Initiation
Jounce Therapeutics initiated  »

Jounce Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.